Sex Differences in Step Count-Blood Pressure Association: A Preliminary Study in Type 2 Diabetes

被引:23
|
作者
Manjoo, Priya [1 ,2 ]
Joseph, Lawrence [1 ]
Pilote, Louise [1 ]
Dasgupta, Kaberi [1 ]
机构
[1] McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, Montreal, PQ, Canada
[2] Vancouver Isl Hlth Author, Dept Med, Victoria, BC, Canada
来源
PLOS ONE | 2010年 / 5卷 / 11期
基金
加拿大健康研究院;
关键词
PHYSICAL-ACTIVITY; EXERCISE; WALKING; MORTALITY; RISK; STEPS/DAY; ACCURACY; PROGRAM; ADULTS;
D O I
10.1371/journal.pone.0014086
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Walking and cardiovascular mortality are inversely associated in type 2 diabetes, but few studies have objectively measured associations of walking with individual cardiovascular risk factors. Such information would be useful for "dosing" daily steps in clinical practice. This study aimed to quantify decrements in blood pressure and glycated hemoglobin (A1C) per 1,000 daily step increments. Methodology/Principal Findings: Two hundred and one subjects with type 2 diabetes underwent assessments of step counts (pedometer-measured), blood pressure, A1C and anthropometric parameters. Due to missing data, the final analysis was conducted on 83 women and 102 men, with a mean age of 60 years. Associations of daily steps with blood pressure and A1C were evaluated using sex-specific multivariate linear regression models (adjusted for age, ethnicity, and BMI). Potential sex differences were confirmed in a combined model (women and men) with interaction terms. Mean values for daily steps, blood pressure, A1C and BMI were 5,357 steps/day; 137/80 mm Hg; 7.7% and 30.4 kg/m(2) respectively. A 1,000 daily step increment among women was associated with a -2.6 (95% CI: -4.1 to -1.1) mm Hg change in systolic and a -1.4 (95% CI: -2.2 to -0.6) mm Hg change in diastolic blood pressure. Among men, corresponding changes were -0.7 (95% CI: -2.1 to 0.7) and -0.6 (95% CI: -1.4 to 0.3) mm Hg, respectively. Sex differences were confirmed in combined models. Step counts and A1C did not demonstrate clinically important associations. Conclusions/Significance: A 1,000 steps/day increment is associated with important blood pressure decrements among women with type 2 diabetes but the data were inconclusive among men. Targeted "dose increments" of 1,000 steps/day in women may lead to measurable blood pressure reductions. This information may be of potential use in the titration or "dosing" of daily steps. No associations were found between step count increments and A1C.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] The mediatory role of androgens on sex differences in glucose homeostasis and incidence of type 2 diabetes: the KORA study
    Raeisi-Dehkordi, Hamidreza
    Thorand, Barbara
    Beigrezaei, Sara
    Peters, Annette
    Rathman, Wolfgang
    Adamski, Jerzy
    Chatelan, Angeline
    van der Schouw, Yvonne T.
    Franco, Oscar H.
    Muka, Taulant
    Nano, Jana
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [42] Blood pressure management in patients with type 2 diabetes mellitus
    Kai, Hisashi
    HYPERTENSION RESEARCH, 2017, 40 (08) : 721 - 729
  • [43] Blood pressure management in patients with type 2 diabetes mellitus
    Hisashi Kai
    Hypertension Research, 2017, 40 : 721 - 729
  • [44] Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
    Lamprea-Montealegre, Julio A.
    de Boer, Ian H.
    DIABETES CARE, 2018, 41 (06) : 1132 - 1133
  • [45] The association between neighbourhood greenspace and type 2 diabetes in a large cross-sectional study
    Bodicoat, Danielle H.
    O'Donovan, Gary
    Dalton, Alice M.
    Gray, Laura J.
    Yates, Thomas
    Edwardson, Charlotte
    Hill, Sian
    Webb, David R.
    Khunti, Kamlesh
    Davies, Melanie J.
    Jones, Andrew P.
    BMJ OPEN, 2014, 4 (12):
  • [46] Type 2 diabetes, high blood pressure and acute pancreatitis
    Bexelius, Tomas S.
    Ljung, Rickard
    Garcia Rodriguez, Luis A.
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (04) : 443 - 445
  • [47] Association of body mass index and blood pressure variability with 10-year mortality and renal disease progression in type 2 diabetes
    Fava, Stephen
    Reiff, Sascha
    ACTA DIABETOLOGICA, 2024, 61 (06) : 747 - 754
  • [48] Association of Brain-Derived Neurotrophic Factor With Cognitive Function: An Investigation of Sex Differences in Patients With Type 2 Diabetes
    Zhen, Yan-Feng
    Liu, Xing-Yu
    Li, Yu-Kai
    Fang, Hui
    Cassidy, Ryan M.
    Zhang, Xiang Yang
    PSYCHOSOMATIC MEDICINE, 2019, 81 (06): : 488 - 494
  • [49] Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes
    Jung, Susanne
    Bosch, Agnes
    Kannenkeril, Dennis
    Karg, Marina, V
    Striepe, Kristina
    Bramlage, Peter
    Ott, Christian
    Schmieder, Roland E.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (06) : 364 - 371
  • [50] The Blood Pressure Response to Exercise in Youth with Impaired Glucose Tolerance and Type 2 Diabetes
    Yardley, Jane E.
    MacMillan, Freya
    Hay, Jacqueline
    Wittmeier, Kristy
    Wicklow, Brandy
    MacIntosh, Andrea
    McGavock, Jonathan
    PEDIATRIC EXERCISE SCIENCE, 2015, 27 (01) : 120 - 127